Concert Pharmaceuticals Stock Forecast NASDAQ:CNCE

Price Target and Analyst Ratings

Most Recent Rating

HC Wainwright is very positive about CNCE and gave it a "Buy" rating on July 02, 2021. The price target was set to $17.00.

Last 30 Days

Historical Ratings

Date	Rating	Action	Authority	Current Price	Target Price
2021-07-02	Buy	Reiterated by	HC Wainwright	$4.15	$17.00
2021-05-04	Buy	Reiterated by	Mizuho	$3.87	$13.00
2021-02-02		Target Lowered by	Truist	$6.97	$30.00 → $22.00
2021-02-02	Buy	Reiterated by	HC Wainwright	$6.97	$25.00 → $17.00
2020-12-16	Buy	Initiated by	Berenberg Bank	$12.75	$25.00
2020-11-04	Outperform	Initiated by	JMP Securities	$10.69
2020-10-02	Buy	Reiterated by	Mizuho	$10.68	$18.00
2020-09-14	Buy	Reiterated by	Mizuho	$10.47	$18.00
2020-06-01	Buy	Reiterated by	Mizuho	$9.74	$18.00

CNCE Stock Trend

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -15.72% during the next 3 months and, with a 90% probability hold a price between $2.65 and $3.29 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-20	$3.14	$3.51	$3.89
2021-09-21	$3.12	$3.50	$3.88
2021-09-22	$3.11	$3.49	$3.87
2021-09-23	$3.10	$3.48	$3.86
2021-09-24	$3.09	$3.47	$3.85
2021-09-27	$3.08	$3.46	$3.83
2021-09-28	$3.07	$3.44	$3.82
2021-09-29	$3.05	$3.43	$3.81
2021-09-30	$3.04	$3.42	$3.80
2021-10-01	$3.03	$3.41	$3.79
2021-10-04	$3.02	$3.40	$3.78
2021-10-05	$3.01	$3.39	$3.76
2021-10-06	$3.00	$3.37	$3.75
2021-10-07	$2.99	$3.36	$3.74
2021-10-08	$2.97	$3.35	$3.73
2021-10-11	$2.96	$3.34	$3.72
2021-10-12	$2.95	$3.33	$3.71
2021-10-13	$2.94	$3.32	$3.70
2021-10-14	$2.93	$3.31	$3.68
2021-10-15	$2.92	$3.29	$3.67
2021-10-18	$2.90	$3.28	$3.66
2021-10-19	$2.89	$3.27	$3.65
2021-10-20	$2.88	$3.26	$3.64
2021-10-21	$2.87	$3.25	$3.63
2021-10-22	$2.86	$3.24	$3.61
2021-10-25	$2.85	$3.22	$3.60
2021-10-26	$2.83	$3.21	$3.59
2021-10-27	$2.82	$3.20	$3.58
2021-10-28	$2.81	$3.19	$3.57
2021-10-29	$2.80	$3.18	$3.56

About Concert Pharmaceuticals

Concert Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule drugs for genetic diseases, inflammatory disease, and neurologic disorders. The companys clinical-stage product candidates include AVP-786, which is in Phase 2 and Phase 3 clinical trials for the treatment of neurologic and psychiatric disorders, including Alzheimers agitation, depressive disorders, and residual schizophrenia; and ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!